Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity
about
Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivityOvercoming the concentration-dependence of responsive probes for magnetic resonance imagingDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersWater and protein dynamics in sedimented systems: a relaxometric investigation.High relaxivity Mn(2+)-based MRI contrast agents.Optimized relaxivity and stability of [Gd(H(2,2)-1,2-HOPO)(H2O)]- for use as an MRI contrast agent.Use of YbIII-centered near-infrared (NIR) luminescence to determine the hydration state of a 3,2-HOPO-based MRI contrast agent1,2-hydroxypyridonate/terephthalamide complexes of gadolinium(III): synthesis, stability, relaxivity, and water exchange properties.Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agentsGd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications.Improving T₁ and T₂ magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes.The importance of water exchange rates in the design of responsive agents for MRI.New Synthetic Approach for the Incorporation of 3,2-Hydroxypyridinone (HOPO) Ligands: Synthesis of Structurally Diverse Poly HOPO Chelators.Synthesis and iron sequestration equilibria of novel exocyclic 3-hydroxy-2-pyridinone donor group siderophore mimics.Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.Silica microparticles as a solid support for gadolinium phosphonate magnetic resonance imaging contrast agents.Conjugation to Biocompatible Dendrimers Increases Lanthanide T2 Relaxivity of Hydroxypyridinone (HOPO) Complexes for Magnetic Resonance Imaging (MRI)Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.Synthesis and chemical reactivity of a 6-Me-3,2-hydroxypyridinone dithiazolide with primary amines: a route to new hexadentate chelators for hard metal(III) ions.Self-assembly between dicarboxylate ions and binuclear europium complexes: moving to water-pH dependence and effects of buffers.Effect of a mesitylene-based ligand cap on the relaxometric properties of Gd(III) hydroxypyridonate MRI contrast agents.A new heptadentate picolinate-based ligand and its corresponding Gd(iii) complex: the effect of pendant picolinate versus acetate on complex properties.Tumor Microenvironment-Enabled Nanotherapy.A highly stable l-alanine-based mono(aquated) Mn(ii) complex as a T1-weighted MRI contrast agent.Synthesis and Characterization of Ligands and their Gadolinium(III) ComplexesStructure, Dynamics, and Computational Studies of Lanthanide-Based Contrast AgentsNew tris-3,4-HOPO lanthanide complexes as potential imaging probes: complex stability and magnetic propertiesMultifrequency Electron Spin-Relaxation Times
P2860
Q24594049-25A3FDCE-30F9-469D-80E3-D15ADF7682DAQ27013727-CA0EB652-35D7-47EE-8B77-952970239D4DQ28235682-5F782459-D4E8-4F40-9C41-C250CE8B2AE5Q30625649-1D983932-C152-4ADD-A54A-13E32EE5E483Q30868530-B21A57C4-02C4-4675-98AE-E0EE12B915E2Q31112386-CE4439A1-0982-4043-86A3-41FA87B56021Q33363624-95ECB3DA-4A35-4D96-9A3C-FAB716020C57Q33386980-C12870B5-329E-402E-AA50-39E7E7315621Q33403791-B488CE6F-C1F9-4427-9987-4951CFA098E9Q33463644-5E3DBDDB-A0A5-4F15-A971-1E1D144A6BDDQ33847006-D66C7411-5FDE-4C47-BA5A-0C56F644CD5DQ33852473-0C54ABF4-2D97-4DCB-A3AC-3D94E33187B3Q34161701-BC1FD032-100E-4DE1-A421-AE9E1F988BBFQ34554929-051D0669-8E4D-44FF-B3BB-E934FCA4A0E1Q35060340-05E3C47D-C8F5-429E-BACF-E0217907A985Q35194065-58D1AEF6-0CB8-41C0-9F16-6D4D9E7F2A60Q35665118-C74A245A-C937-41B4-AA2D-AFA9CA5710A1Q36112041-9068E316-16CB-48E8-93AC-356D7705A523Q36714422-BF81D0CA-FDC9-47CC-A8A1-C456BA0FED8CQ37142843-F64ECB72-BE15-4FFE-8F82-E5FC4AAC0A64Q41130080-B64AB9C2-7899-40B3-9BF8-AA5823E1AF1CQ41156109-60416195-D869-49D9-90B8-F8558370F8CCQ43063011-E0DA7A3A-2EFF-4B71-93A5-062C2AF5F146Q47756394-4B96B40D-63E4-49B3-9C60-9D7C531E6B48Q47761233-E3ECB3B3-3D32-4A64-9234-CCDF10F2522DQ47956124-1D382D61-75E5-40AB-953A-9B74BC5A64AFQ57340454-42712E7A-6696-45DE-9550-C06E93E3E1BBQ57391311-21A658FE-959C-4C5F-A094-2E54B2F4CF24Q58374529-AF74BBD3-DEE8-40C2-9674-AA3C59E1E8A2Q58819829-BA59B8F3-C938-4B7E-9441-89F635EDE024
P2860
Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Highly soluble tris-hydroxypyr ...... elaxation, and high relaxivity
@ast
Highly soluble tris-hydroxypyr ...... elaxation, and high relaxivity
@en
type
label
Highly soluble tris-hydroxypyr ...... elaxation, and high relaxivity
@ast
Highly soluble tris-hydroxypyr ...... elaxation, and high relaxivity
@en
prefLabel
Highly soluble tris-hydroxypyr ...... elaxation, and high relaxivity
@ast
Highly soluble tris-hydroxypyr ...... elaxation, and high relaxivity
@en
P2093
P2860
P50
P356
P1476
Highly soluble tris-hydroxypyr ...... elaxation, and high relaxivity
@en
P2093
Benjamin P Hay
Eric J Werner
Kenneth N Raymond
Stefano Avedano
P2860
P304
P356
10.1021/JA068026Z
P407
P577
2007-01-30T00:00:00Z